Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Chest|February 9, 2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGordon H Guyatt, Susan L Norris, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
The association between platelet transfusions and bleeding in critically ill patients with thrombocytopeniaDonald M Arnold, Francois Lauzier, Martin Albert, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Stroke|May 10, 2021
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 SubstudyAndrew M Demchuk, Patrick Yue, Elena Zotova, et al.
Circulation|February 21, 2023
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J Milling, Saskia Middeldorp, Lizhen Xu, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
Circulation|January 21, 2009
Acute kidney injury after cardiac surgery: focus on modifiable risk factorsKeyvan Karkouti, Duminda N Wijeysundera, Terrence M Yau, et al.
Intensive Care Medicine|August 15, 2013
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxisFrançois Lauzier, Donald M Arnold, Christian Rabbat, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 11, 2020
Canadian stroke best practice recommendations: <i>Management of Spontaneous Intracerebral Hemorrhage</i>, 7th Edition Update 2020Ashkan Shoamanesh, M Patrice Lindsay, Lana A Castellucci, et al.
JAMA|October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical TrialJeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Chest|February 9, 2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGordon H Guyatt, Susan L Norris, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
The association between platelet transfusions and bleeding in critically ill patients with thrombocytopeniaDonald M Arnold, Francois Lauzier, Martin Albert, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Stroke|May 10, 2021
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 SubstudyAndrew M Demchuk, Patrick Yue, Elena Zotova, et al.
Circulation|February 21, 2023
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J Milling, Saskia Middeldorp, Lizhen Xu, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
Circulation|January 21, 2009
Acute kidney injury after cardiac surgery: focus on modifiable risk factorsKeyvan Karkouti, Duminda N Wijeysundera, Terrence M Yau, et al.
Intensive Care Medicine|August 15, 2013
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxisFrançois Lauzier, Donald M Arnold, Christian Rabbat, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 11, 2020
Canadian stroke best practice recommendations: <i>Management of Spontaneous Intracerebral Hemorrhage</i>, 7th Edition Update 2020Ashkan Shoamanesh, M Patrice Lindsay, Lana A Castellucci, et al.
JAMA|October 22, 2019
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical TrialJeannie Callum, Michael E Farkouh, Damon C Scales, et al.
Pageof 29